122 related articles for article (PubMed ID: 38591310)
1. Krukenburg tumour: Role of 18F-FDG PET/CT in identifying the primary site.
Usmani S; Murad S; Kandari FA; Maraghy MA
J Pak Med Assoc; 2024 Mar; 74(3):597-598. PubMed ID: 38591310
[TBL] [Abstract][Full Text] [Related]
2. [Malignant tumor with false negative 18F-FDG PET image].
Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
[TBL] [Abstract][Full Text] [Related]
3. Unilateral ovarian metastasis from gastric mucinous adenocarcinoma visualized on FDG PET/CT.
Tamam MO; Mulazimoglu M; Kamali G; Eker O; Ozpacaci T
Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():1-3. PubMed ID: 23090794
[TBL] [Abstract][Full Text] [Related]
4. The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies.
Tian J; Chen L; Wei B; Shao M; Ding Y; Yin D; Yao S
Nucl Med Commun; 2004 Aug; 25(8):825-31. PubMed ID: 15266178
[TBL] [Abstract][Full Text] [Related]
5. Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?
Perlaza P; Ortín J; Pagès M; Buxó E; Fernández-Esparrach G; Colletti PM; Rubello D; Mayoral M; Sánchez N; Ruiz C; Ginés A; Fuster D
Clin Nucl Med; 2018 Jun; 43(6):402-410. PubMed ID: 29485442
[TBL] [Abstract][Full Text] [Related]
6. Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment.
Bosch KD; Chicklore S; Cook GJ; Davies AR; Kelly M; Gossage JA; Baker CR
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):759-767. PubMed ID: 31377821
[TBL] [Abstract][Full Text] [Related]
7. Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin.
Kaya AO; Coskun U; Unlu M; Akdemir UO; Ozdemir NY; Zengin N; Benekli M; Yildiz R; Yaman E; Ozturk B; Gumus M; Uner A; Yamac D; Ucgul E; Buyukberber S
Asian Pac J Cancer Prev; 2008; 9(4):683-6. PubMed ID: 19256759
[TBL] [Abstract][Full Text] [Related]
8. Dual-Tracer PET/CT Using 18F-FDG and 11C-Acetate in Gastric Adenocarcinoma With Liver Metastasis.
Vardhanabhuti V; Lo AW; Lee EY; Law SY
Clin Nucl Med; 2016 Nov; 41(11):864-865. PubMed ID: 27648704
[TBL] [Abstract][Full Text] [Related]
9. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results.
Sun L; Su XH; Guan YS; Pan WM; Luo ZM; Wei JH; Wu H
World J Gastroenterol; 2008 Aug; 14(29):4627-32. PubMed ID: 18698676
[TBL] [Abstract][Full Text] [Related]
10. Role of FDG-PET/CT in follow-up of patients treated with resective gastric surgery for tumour.
Graziosi L; Bugiantella W; Cavazzoni E; Cantarella F; Porcari M; Baffa N; Donini A
Ann Ital Chir; 2011; 82(2):125-9. PubMed ID: 21682102
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
Lim SM; Kim H; Kang B; Kim HS; Rha SY; Noh SH; Hyung WJ; Cheong JH; Kim HI; Chung HC; Yun M; Cho A; Jung M
Ann Nucl Med; 2016 May; 30(4):279-86. PubMed ID: 26837515
[TBL] [Abstract][Full Text] [Related]
12. 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC).
Gertsen EC; Brenkman HJF; van Hillegersberg R; van Sandick JW; van Berge Henegouwen MI; Gisbertz SS; Luyer MDP; Nieuwenhuijzen GAP; van Lanschot JJB; Lagarde SM; Wijnhoven BPL; de Steur WO; Hartgrink HH; Stoot JHMB; Hulsewe KWE; Spillenaar Bilgen EJ; van Det MJ; Kouwenhoven EA; van der Peet DL; Daams F; van Grieken NCT; Heisterkamp J; van Etten B; van den Berg JW; Pierie JP; Eker HH; Thijssen AY; Belt EJT; van Duijvendijk P; Wassenaar E; van Laarhoven HWM; Wevers KP; Hol L; Wessels FJ; Haj Mohammad N; van der Meulen MP; Frederix GWJ; Vegt E; Siersema PD; Ruurda JP;
JAMA Surg; 2021 Dec; 156(12):e215340. PubMed ID: 34705049
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population.
Sharma P; Singh H; Suman SK; Sharma A; Reddy RM; Thulkar S; Bal C; Malhotra A; Kumar R
Nucl Med Commun; 2012 Sep; 33(9):960-6. PubMed ID: 22692579
[TBL] [Abstract][Full Text] [Related]
14. Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET.
Kameyama R; Yamamoto Y; Izuishi K; Takebayashi R; Hagiike M; Murota M; Kaji M; Haba R; Nishiyama Y
Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):382-8. PubMed ID: 18985344
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for PET/CT with esophagogastric junction adenocarcinoma?
Fuster D; Mayoral M; Rubello D; Pineda E; Fernández-Esparrach G; Pagès M; Colletti PM; Pons F
Clin Nucl Med; 2015 Mar; 40(3):e201-7. PubMed ID: 25546207
[TBL] [Abstract][Full Text] [Related]
16. Gastric recurrence of a primary colon plasmacytoma: staging and evaluating response to therapy with 18F-FDG PET/CT.
Makis W; Ciarallo A; Hickeson M; Lisbona R
Br J Radiol; 2012 Jan; 85(1009):e4-9. PubMed ID: 22190759
[TBL] [Abstract][Full Text] [Related]
17. Complete splenic vein tumour thrombus in primary gastric malignancy on F18-fluorodeoxyglucose positron emission tomography-computed tomography.
Ahmad W; Asghar N; Zafar T; Bashir H
J Pak Med Assoc; 2021 Jan; 71(1(A)):175-176. PubMed ID: 33484552
[TBL] [Abstract][Full Text] [Related]
18. Progressing Sclerosing Mesenteritis (Mesenteric Panniculitis) Mimics Progression of Malignancy After Neoadjuvant Chemotherapy for Gastric Adenocarcinoma on Serial 18F-FDG PET/CT.
Makis W
Clin Nucl Med; 2016 Apr; 41(4):313-6. PubMed ID: 26359565
[TBL] [Abstract][Full Text] [Related]
19. The impact of baseline
Foley KG; Coomer W; Coles B; Bradley KM
Br J Radiol; 2022 Oct; 95(1139):20220437. PubMed ID: 36129138
[TBL] [Abstract][Full Text] [Related]
20. Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy.
Manoharan V; Lee S; Chong S; Yap J; Coupe N; Wilson R; Merrett N; Ng W; Lin M
Ann Nucl Med; 2017 May; 31(4):315-323. PubMed ID: 28299585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]